This is copied from a post in the Slowtwitch.com forum ... posted by a guy
with the handle "Peanut." I don't know his background, but he makes some
interesting points.
Here's something to remember, though. First of, a couple of quotes:
"Although the test is new in sports, the science behind it (cytology) has
been successfully used for 10 years in hospitals for organ transplants and
pregnant women." - Cycling News
"Everyone has a whole range of blood groups - not just the ABO set that
everyone is familiar with," says Ashenden. "There are 10 or 20 minor blood
groups." - from Ashenden, manager of the group that developed the tests.
"We haven't declared all the antigens that we test," he says. "Even if they
read the article [Haematologica. 2003 Nov;88(11):1284-95] and found a match
for the antigens mentioned - one in a million - there is no way they can get
a match for the other 'mystery' antigens. - again from Ashenden
Remember that there are at least 10, possibly 20 or more different tests
here, each applied individually to a blood sample. Each test requires a
different protein to be developed which attaches itself to the rbc if and
only if the rbcs have a specific antigen present on the surface of the rbc.
And although the basis for the tests have been around for 10 years, even the
published article from 2 years ago doesn't declare all of the antigens to be
tested for, since they have additional 'mystery' antigens.
So the $64,000 question is: have the mystery antigens, and the developed
proteins to mark them, been vetted out by scientists outside of those with a
vested interest in the test (i.e. Ashenden's group, which receives funding
from USADA). Have the newer tests been tested on a wide distribution of
blood samples? Is there any reason to believe that one of the tests may show
a false positive?
Also, remember that if there is a deficiency found in one of the test's
proteins, such that it can be proven that it only selectively attaches to a
subset of the rbcs for a good scientific reason other than blood
transfusion, then a false positive would be the result. And if you repeated
that exact same test on a fresh sample of the same blood, you would repeat
the false positive, again and again.
I can't answer these questions. You can't answer them (unless you're also a
cytologist with expertise in the area). Everyone's lawyers can't answer them
directly either. So it comes down to having experts in the field review the
data, the developed test proteins, the test results, etc., to see if any
holes in Ashenden's group's scientific method can be found. Until then, all
we can do is wait and see.
--
Bob C.
"Of course it hurts. The trick is not minding that it hurts."
T. E. Lawrence (of Arabia)